Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_assertion type Assertion NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_head.
- NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_assertion description "[Conversely, the PAR1 antagonist was beneficial to hMPV infection by decreasing weight loss and clinical signs and by significantly reducing pulmonary inflammation, pro-inflammatory cytokine levels (including IL-6, KC and MCP-1) and recruitment of immune cells to the lungs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_provenance.
- NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_assertion evidence source_evidence_literature NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_provenance.
- NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_assertion SIO_000772 24015257 NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_provenance.
- NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_assertion wasDerivedFrom befree-2016 NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_provenance.
- NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_assertion wasGeneratedBy ECO_0000203 NP1108692.RAAIIZr3uFjnuyy2sjeG6vxU3Qx8DK_uT5Xm5jtFK5C4s130_provenance.